KALEO

Kaléo is a global drug-delivery device company, providing innovation in the field of autoinjector technology. Kaléo’s patented Aerio™ platform, with a novel configuration and extensive human factors engineering, powers its portfolio of autoinjector products, as well as products under development for third parties.

Kaléo is privately held. It was originally named Intelliject, and was founded by twin brothers Eric and Evan Edwards, who have both suffered with serious allergies to peanuts and various other items.